Skip to main content

Sources last read

Brand guide · Orforglipron

What is Foundayo?

Foundayo is a brand of Orforglipron. FDA has approved it for 1 use. People take it once daily, at any time of day, with or without food. The first labeled dose is 0.8 mg. The highest is 17.2 mg.

Source: Current FDA label, checked 2026-09-06

What matters first

Medicine
Orforglipron
How often
Once daily, at any time of day, with or without food
Starting dose
0.8 mg
Highest labeled dose
17.2 mg

Choose what you need

Go straight to the answer

DosageFoundayo dosage scheduleSee every labeled step from 0.8 mg to 17.2 mg.SafetyFoundayo side effectsSee common trial results and serious warnings from the current label.PriceWhat Foundayo costsCompare the list price, published cash offers and key limits.

Approved uses

What is Foundayo approved to treat?

Adults with obesity, or with overweight plus at least one related health condition.

Labeled maintenance: The label names no maintenance dose; after 5.5 mg, further increases depend on response and how well people handle it

Not an approved use: The label covers weight management in adults. It does not establish use in anyone under 18, and it says taking Foundayo with another GLP-1 receptor agonist is not recommended.

The product itself

How Foundayo comes

Film-coated tablet

0.8, 2.5, 5.5, 9, 14.5 and 17.2 mg

Bottle of 30 tablets

Eli Lilly and Company makes Foundayo under NDA 220934. The label says it is given tablet, swallowed whole.

1primary source, each with the day we read it — open the documents used on this page
Foundayo is a registered brand name. HealthspanLedger is not affiliated with or endorsed by Eli Lilly and Company. This page summarizes public FDA records and does not give medical advice.